HNI (HNI) Financials

$41.15 +0.20 (+0.50%)

Closing price 03:59 PM Eastern

Extended Trading

$41.18 +0.02 (+0.05%)

As of 04:07 PM Eastern

Annual Income Statements for HNI

This table shows HNI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	124	49	140
Consolidated Net Income / (Loss)	124	49	140
Net Income / (Loss) Continuing Operations	124	49	140
Total Pre-Tax Income	146	65	179
Total Operating Income	155	90	207
Total Gross Profit	835	948	1,033
Total Revenue	2,362	2,434	2,526
Operating Revenue	2,362	2,434	2,526
Total Cost of Revenue	1,527	1,486	1,493
Operating Cost of Revenue	1,527	1,486	1,493
Total Operating Expenses	680	858	827
Selling, General & Admin Expense	723	813	821
Restructuring Charge	6.70	45	6.20
Other Special Charges / (Income)	-50	0.00	0.00
Total Other Income / (Expense), net	-8.80	-26	-27
Interest & Investment Income	-8.80	-26	-27
Income Tax Expense	23	16	40
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.00
Basic Earnings per Share	$2.97	$1.11	$2.95
Weighted Average Basic Shares Outstanding	41.70M	44.50M	47.40M
Diluted Earnings per Share	$2.94	$1.09	$2.88
Weighted Average Diluted Shares Outstanding	42.20M	45.40M	48.50M
Weighted Average Basic & Diluted Shares Outstanding	41.41M	46.89M	47.02M
Cash Dividends to Common per Share	$1.27	$1.28	$1.31

This table shows HNI's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	63	16	1.60	-13	38	23	18	36	48	38
Consolidated Net Income / (Loss)	63	16	1.60	-13	38	23	18	36	48	38
Net Income / (Loss) Continuing Operations	63	16	1.50	-13	38	23	18	36	48	38
Total Pre-Tax Income	80	21	3.80	-9.00	47	23	22	46	62	50
Total Operating Income	82	23	6.40	-3.60	57	31	30	53	69	55
Total Gross Profit	210	208	174	216	285	273	233	261	279	261
Total Revenue	599	569	479	564	712	680	588	624	672	643
Operating Revenue	599	569	479	564	712	680	588	624	672	643
Total Cost of Revenue	389	361	305	348	426	407	355	362	393	382
Operating Cost of Revenue	389	361	305	348	426	407	355	362	393	382
Total Operating Expenses	128	185	168	219	229	242	203	208	210	206
Selling, General & Admin Expense	178	179	168	211	223	211	203	206	208	203
Restructuring Charge	0.00	-	0.00	8.10	5.30	31	0.10	2.00	1.60	2.50
Total Other Income / (Expense), net	-2.50	-2.30	-2.70	-5.50	-9.40	-7.90	-7.60	-7.40	-7.10	-5.10
Interest & Investment Income	-2.40	-2.30	-2.70	-5.50	-9.40	-7.90	-7.60	-7.40	-7.10	-5.10
Income Tax Expense	16	4.30	2.20	3.80	9.60	-	4.30	10	14	11
Basic Earnings per Share	$1.53	$0.38	$0.04	($0.30)	$0.81	$0.56	$0.38	$0.76	$1.00	$0.81
Weighted Average Basic Shares Outstanding	41.30M	41.70M	41.50M	43.30M	46.60M	44.50M	47.10M	47.20M	47.70M	47.40M
Diluted Earnings per Share	$1.51	$0.38	$0.04	($0.30)	$0.80	$0.55	$0.37	$0.75	$0.98	$0.78
Weighted Average Diluted Shares Outstanding	41.80M	42.20M	42.10M	43.30M	47.30M	45.40M	48.10M	48.20M	48.70M	48.50M
Weighted Average Basic & Diluted Shares Outstanding	41.36M	41.41M	41.70M	46.55M	46.58M	46.89M	47.30M	47.14M	47.80M	47.02M

This table details how cash moves in and out of HNI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	-35	12	-6.40
Net Cash From Operating Activities	81	268	227
Net Cash From Continuing Operating Activities	81	268	227
Net Income / (Loss) Continuing Operations	124	49	140
Consolidated Net Income / (Loss)	124	49	140
Depreciation Expense	84	95	108
Non-Cash Adjustments To Reconcile Net Income	-31	54	13
Changes in Operating Assets and Liabilities, net	-96	69	-33
Net Cash From Investing Activities	-11	-445	-51
Net Cash From Continuing Investing Activities	-11	-445	-51
Purchase of Property, Plant & Equipment	-60	-78	-51
Acquisitions	-20	-371	-2.30
Purchase of Investments	-2.80	-5.70	-3.20
Divestitures	70	2.70	0.00
Sale and/or Maturity of Investments	2.30	5.40	4.70
Other Investing Activities, net	0.00	1.60	0.40
Net Cash From Financing Activities	-105	189	-182
Net Cash From Continuing Financing Activities	-105	189	-182
Repayment of Debt	-406	-439	-421
Repurchase of Common Equity	-65	-0.30	-66
Payment of Dividends	-53	-59	-64
Issuance of Debt	414	684	317
Issuance of Common Equity	4.70	2.30	51

This table details how cash moves in and out of HNI's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	1.50	-3.60	-0.50	6.80	0.60	4.60	-2.00	1.30	6.00	-12
Net Cash From Operating Activities	59	47	17	23	123	105	-4.30	51	129	51
Net Cash From Continuing Operating Activities	59	47	17	22	123	105	-4.20	51	128	51
Net Income / (Loss) Continuing Operations	63	16	1.60	-13	38	23	18	36	48	38
Consolidated Net Income / (Loss)	63	16	1.60	-13	38	23	18	36	48	38
Depreciation Expense	21	21	20	23	26	27	26	26	27	28
Non-Cash Adjustments To Reconcile Net Income	-53	12	5.40	5.00	6.90	37	8.60	5.90	4.20	-6.10
Changes in Operating Assets and Liabilities, net	28	-2.10	-9.70	7.70	52	19	-57	-17	49	-8.60
Net Cash From Investing Activities	56	-24	-20	-391	-17	-17	-11	-16	-15	-9.30
Net Cash From Continuing Investing Activities	56	-24	-20	-391	-17	-17	-11	-17	-15	-9.40
Purchase of Property, Plant & Equipment	-14	-18	-	-	-24	-16	-11	-17	-14	-9.40
Acquisitions	-1.60	-3.60	-0.20	-373	2.60	-0.10	-0.50	-0.90	-0.60	-0.30
Purchase of Investments	-0.50	-0.50	-1.60	-1.50	-0.70	-1.90	-0.60	-1.30	-1.20	-0.10
Sale and/or Maturity of Investments	0.40	0.40	1.50	1.50	1.00	1.40	1.20	2.20	1.10	0.20
Other Investing Activities, net	-	-	-20	20	1.30	0.10	0.10	0.10	-	0.20
Net Cash From Financing Activities	-120	-27	2.10	375	-105	-83	13	-34	-108	-54
Net Cash From Continuing Financing Activities	-120	-27	2.20	375	-105	-84	13	-34	-108	-54
Repayment of Debt	-137	-107	-82	-86	-144	-127	-87	-115	-161	-57
Repurchase of Common Equity	-	-	0.00	-	-	-0.30	-2.60	-11	-11	-41
Payment of Dividends	-13	-13	-14	-15	-15	-15	-17	-16	-16	-16
Issuance of Debt	30	92	97	475	53	59	119	107	37	54
Issuance of Common Equity	0.60	0.70	0.60	0.60	0.60	0.50	0.60	0.60	44	5.80

This table presents HNI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Total Assets	1,415	1,929	1,875
Total Current Assets	469	536	525
Cash & Equivalents	17	29	23
Short-Term Investments	2.00	5.60	6.40
Accounts Receivable	215	-3.50	-2.00
Inventories, net	180	197	194
Prepaid Expenses	54	61	55
Other Current Assets	-	247	248
Plant, Property, & Equipment, net	353	555	530
Plant, Property & Equipment, gross	943	1,194	1,178
Accumulated Depreciation	590	639	649
Total Noncurrent Assets	593	838	821
Noncurrent Note & Lease Receivables	11	12	14
Goodwill	440	652	624
Other Noncurrent Operating Assets	142	174	183
Total Liabilities & Shareholders' Equity	1,415	1,929	1,875
Total Liabilities	798	1,167	1,035
Total Current Liabilities	395	464	478
Short-Term Debt	1.30	7.50	50
Accounts Payable	368	419	391
Other Current Liabilities	26	38	36
Total Noncurrent Liabilities	403	703	557
Long-Term Debt	189	428	294
Capital Lease Obligations	7.70	7.90	8.90
Noncurrent Deferred & Payable Income Tax Liabilities	61	85	72
Other Noncurrent Operating Liabilities	145	182	183
Total Equity & Noncontrolling Interests	617	762	840
Total Preferred & Common Equity	617	761	840
Preferred Stock	0.00	0.00	0.00
Total Common Equity	617	762	840
Common Stock	91	249	249
Retained Earnings	534	524	600
Accumulated Other Comprehensive Income / (Loss)	-8.00	-11	-8.30
Noncontrolling Interest	0.30	0.30	0.30

This table presents HNI's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,499	1,383	2,076	2,017	1,913	1,941	1,913
Total Current Assets	540	447	598	572	527	568	562
Cash & Equivalents	21	17	24	24	27	28	34
Short-Term Investments	2.00	2.00	5.70	5.80	5.50	5.30	5.90
Accounts Receivable	-2.40	188	256	259	229	257	259
Inventories, net	222	191	235	229	212	223	210
Prepaid Expenses	53	50	59	55	54	55	52
Plant, Property, & Equipment, net	349	355	580	560	552	548	540
Plant, Property & Equipment, gross	945	956	1,193	1,184	1,205	1,204	1,196
Accumulated Depreciation	595	601	613	624	653	656	657
Total Noncurrent Assets	610	581	898	885	833	825	812
Noncurrent Note & Lease Receivables	11	11	12	12	12	13	12
Goodwill	452	433	702	693	646	639	632
Other Noncurrent Operating Assets	147	137	185	179	176	173	169
Total Liabilities & Shareholders' Equity	1,499	1,383	2,076	2,017	1,913	1,941	1,913
Total Liabilities	892	770	1,360	1,276	1,141	1,153	1,066
Total Current Liabilities	460	353	489	502	408	474	514
Short-Term Debt	1.20	1.60	1.10	15	13	51	51
Accounts Payable	435	326	439	451	364	391	431
Other Current Liabilities	24	25	35	36	31	33	32
Total Noncurrent Liabilities	432	1,030	1,586	1,515	1,505	1,467	1,399
Long-Term Debt	200	206	597	493	460	412	295
Noncurrent Deferred & Payable Income Tax Liabilities	65	60	73	82	83	78	73
Other Noncurrent Operating Liabilities	160	764	916	939	962	977	1,031
Total Equity & Noncontrolling Interests	606	0.30	0.30	0.30	0.30	0.30	0.30
Total Preferred & Common Equity	606	613	715	741	772	788	847
Total Common Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.30	0.30	0.30	0.30	0.30	0.30	0.30

This table displays calculated financial ratios and metrics derived from HNI's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	8.12%	3.06%	3.80%
EBITDA Growth	42.08%	-22.64%	69.71%
EBIT Growth	81.73%	-41.82%	128.68%
NOPAT Growth	101.38%	-47.80%	134.33%
Net Income Growth	107.19%	-60.29%	183.54%
EPS Growth	116.18%	-62.93%	164.22%
Operating Cash Flow Growth	-38.30%	229.43%	-15.25%
Free Cash Flow Firm Growth	-190.84%	43.01%	154.21%
Invested Capital Growth	540.10%	47.30%	-0.51%
Revenue Q/Q Growth	-1.42%	4.77%	-1.45%
EBITDA Q/Q Growth	4.68%	7.93%	8.60%
EBIT Q/Q Growth	7.70%	9.32%	13.03%
NOPAT Q/Q Growth	7.11%	21.51%	8.25%
Net Income Q/Q Growth	7.01%	14.69%	12.68%
EPS Q/Q Growth	6.52%	18.48%	8.68%
Operating Cash Flow Q/Q Growth	5.45%	27.50%	-19.18%
Free Cash Flow Firm Q/Q Growth	-3,147.37%	-183.06%	-48.15%
Invested Capital Q/Q Growth	0.37%	144.77%	281.47%
Profitability Metrics	-	-	-
Gross Margin	35.35%	38.96%	40.90%
EBITDA Margin	10.14%	7.61%	12.44%
Operating Margin	6.57%	3.71%	8.17%
EBIT Margin	6.57%	3.71%	8.17%
Profit (Net Income) Margin	5.25%	2.02%	5.52%
Tax Burden Percent	84.63%	75.93%	77.80%
Interest Burden Percent	94.33%	71.76%	86.83%
Effective Tax Rate	15.37%	24.07%	22.20%
Return on Invested Capital (ROIC)	28.58%	6.97%	13.76%
ROIC Less NNEP Spread (ROIC-NNEP)	33.76%	0.38%	7.99%
Return on Net Nonoperating Assets (RNNOA)	-8.04%	0.16%	3.66%
Return on Equity (ROE)	20.54%	7.14%	17.41%
Cash Return on Invested Capital (CROIC)	-117.37%	-31.28%	14.27%
Operating Return on Assets (OROA)	10.66%	5.40%	10.86%
Return on Assets (ROA)	8.51%	2.94%	7.33%
Return on Common Equity (ROCE)	20.53%	7.13%	17.41%
Return on Equity Simple (ROE_SIMPLE)	20.10%	6.46%	16.61%
Net Operating Profit after Tax (NOPAT)	131	69	161
NOPAT Margin	5.56%	2.82%	6.36%
Net Nonoperating Expense Percent (NNEP)	-5.18%	6.59%	5.77%
Return On Investment Capital (ROIC_SIMPLE)	16.12%	5.69%	13.46%
Cost of Revenue to Revenue	64.65%	61.04%	59.10%
SG&A Expenses to Revenue	30.63%	33.41%	32.49%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	28.78%	35.25%	32.73%
Earnings before Interest and Taxes (EBIT)	155	90	207
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	239	185	314
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.77	2.47	2.87
Price to Tangible Book Value (P/TBV)	6.18	17.18	11.19
Price to Revenue (P/Rev)	0.46	0.77	0.96
Price to Earnings (P/E)	8.81	38.26	17.31
Dividend Yield	4.81%	3.17%	2.59%
Earnings Yield	11.35%	2.61%	5.78%
Enterprise Value to Invested Capital (EV/IC)	1.60	1.96	2.35
Enterprise Value to Revenue (EV/Rev)	0.54	0.94	1.08
Enterprise Value to EBITDA (EV/EBITDA)	5.31	12.38	8.71
Enterprise Value to EBIT (EV/EBIT)	8.18	25.38	13.26
Enterprise Value to NOPAT (EV/NOPAT)	9.67	33.43	17.05
Enterprise Value to Operating Cash Flow (EV/OCF)	15.64	8.57	12.08
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	16.43
Leverage & Solvency	-	-	-
Debt to Equity	0.32	0.58	0.42
Long-Term Debt to Equity	0.32	0.57	0.36
Financial Leverage	-0.24	0.43	0.46
Leverage Ratio	2.41	2.43	2.37
Compound Leverage Factor	2.28	1.74	2.06
Debt to Total Capital	24.28%	36.81%	29.61%
Short-Term Debt to Total Capital	0.16%	0.62%	4.21%
Long-Term Debt to Total Capital	24.12%	36.18%	25.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.02%	0.03%
Common Equity to Total Capital	75.68%	63.17%	70.36%
Debt to EBITDA	0.83	2.40	1.12
Net Debt to EBITDA	0.75	2.21	1.03
Long-Term Debt to EBITDA	0.82	2.36	0.96
Debt to NOPAT	1.51	6.47	2.20
Net Debt to NOPAT	1.36	5.97	2.02
Long-Term Debt to NOPAT	1.50	6.36	1.89
Altman Z-Score	3.44	2.81	3.59
Noncontrolling Interest Sharing Ratio	0.05%	0.04%	0.04%
Liquidity Ratios	-	-	-
Current Ratio	1.19	1.16	1.10
Quick Ratio	0.59	0.07	0.06
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-539	-307	167
Operating Cash Flow to CapEx	135.33%	342.51%	448.02%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.62	1.46	1.33
Accounts Receivable Turnover	10.44	0.00	0.00
Inventory Turnover	8.44	7.89	7.64
Fixed Asset Turnover	6.57	5.36	4.66
Accounts Payable Turnover	3.63	3.78	3.69
Days Sales Outstanding (DSO)	34.96	0.00	0.00
Days Inventory Outstanding (DIO)	43.23	46.27	47.78
Days Payable Outstanding (DPO)	100.58	96.60	99.00
Cash Conversion Cycle (CCC)	-22.39	-50.33	-51.22
Capital & Investment Metrics	-	-	-
Invested Capital	795	1,171	1,165
Invested Capital Turnover	5.14	2.48	2.16
Increase / (Decrease) in Invested Capital	671	376	-6.00
Enterprise Value (EV)	1,270	2,292	2,739
Market Capitalization	1,091	1,882	2,414
Book Value per Share	$14.90	$16.35	$17.57
Tangible Book Value per Share	$4.27	$2.35	$4.51
Total Capital	815	1,206	1,194
Total Debt	198	444	354
Total Long-Term Debt	197	436	303
Net Debt	178	409	325
Capital Expenditures (CapEx)	60	78	51
Debt-free, Cash-free Net Working Capital (DFCFNWC)	56	45	68
Debt-free Net Working Capital (DFNWC)	75	80	97
Net Working Capital (NWC)	74	72	47
Net Nonoperating Expense (NNE)	7.45	19	21
Net Nonoperating Obligations (NNO)	178	409	325
Total Depreciation and Amortization (D&A)	84	95	108
Debt-free, Cash-free Net Working Capital to Revenue	2.37%	1.86%	2.71%
Debt-free Net Working Capital to Revenue	3.19%	3.27%	3.85%
Net Working Capital to Revenue	3.14%	2.97%	1.86%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$2.97	$1.11	$2.95
Adjusted Weighted Average Basic Shares Outstanding	41.70M	44.50M	47.40M
Adjusted Diluted Earnings per Share	$2.94	$1.09	$2.88
Adjusted Weighted Average Diluted Shares Outstanding	42.20M	45.40M	48.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	41.41M	46.89M	47.02M
Normalized Net Operating Profit after Tax (NOPAT)	94	103	165
Normalized NOPAT Margin	4.00%	4.21%	6.55%
Pre Tax Income Margin	6.20%	2.66%	7.10%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	42.94%	118.90%	45.59%
Augmented Payout Ratio	95.56%	119.51%	92.76%

This table displays calculated financial ratios and metrics derived from HNI's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.06%	-5.62%	-16.29%	-9.36%	18.84%	19.47%	22.73%	10.68%	-5.54%	-5.49%
EBITDA Growth	117.55%	32.42%	-36.14%	-62.96%	-19.92%	31.12%	111.70%	320.00%	16.75%	43.46%
EBIT Growth	209.85%	93.28%	-68.63%	-112.00%	-30.56%	33.48%	364.06%	1,583.33%	21.30%	77.52%
NOPAT Growth	215.31%	91.68%	-82.79%	-107.73%	-30.32%	68.69%	786.73%	1,758.39%	16.91%	37.36%
Net Income Growth	228.65%	99.22%	-88.73%	-142.24%	-40.10%	38.65%	1,006.25%	381.25%	25.66%	69.47%
EPS Growth	251.16%	90.00%	-87.88%	-141.67%	-47.02%	44.74%	825.00%	350.00%	22.50%	41.82%
Operating Cash Flow Growth	15.43%	9.74%	144.36%	63.04%	107.61%	121.99%	-124.86%	128.00%	4.73%	-51.24%
Free Cash Flow Firm Growth	-43.48%	-221.28%	-93.66%	376.41%	999.26%	47.09%	-813.84%	-32.75%	-37.06%	113.95%
Invested Capital Growth	15.27%	540.10%	-13.37%	-32.02%	-39.60%	47.30%	132.95%	-23.97%	-36.16%	-0.51%
Revenue Q/Q Growth	-3.68%	-4.98%	-15.80%	17.62%	26.28%	-4.47%	-13.50%	6.07%	7.78%	-4.42%
EBITDA Q/Q Growth	100.58%	-57.53%	-39.36%	-28.30%	333.68%	-30.46%	-2.09%	42.25%	20.55%	-14.55%
EBIT Q/Q Growth	172.67%	-71.88%	-72.17%	-156.25%	1,677.78%	-45.95%	-3.26%	79.80%	29.03%	-20.90%
NOPAT Q/Q Growth	99.47%	-72.00%	-85.19%	-193.52%	1,897.47%	-32.22%	-22.17%	74.90%	26.72%	-20.37%
Net Income Q/Q Growth	108.25%	-74.17%	-90.18%	-900.00%	395.31%	-40.21%	-21.68%	103.39%	31.94%	-19.37%
EPS Q/Q Growth	109.72%	-74.83%	-89.47%	-850.00%	366.67%	-31.25%	-32.73%	102.70%	30.67%	-20.41%
Operating Cash Flow Q/Q Growth	328.26%	-19.97%	-63.42%	30.06%	445.33%	-14.43%	-104.10%	1,293.02%	150.49%	-60.16%
Free Cash Flow Firm Q/Q Growth	58.07%	-1,534.73%	104.88%	725.77%	36.41%	-196.18%	-153.61%	177.80%	27.67%	-78.68%
Invested Capital Q/Q Growth	-4.53%	0.37%	-76.21%	198.25%	-15.18%	144.77%	9.77%	-2.66%	-28.78%	281.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.99%	36.54%	36.38%	38.24%	40.09%	40.19%	39.59%	41.90%	41.48%	40.54%
EBITDA Margin	17.18%	7.68%	5.53%	3.37%	11.58%	8.43%	9.54%	12.79%	14.31%	12.79%
Operating Margin	13.68%	4.04%	1.34%	-0.64%	7.98%	4.52%	5.05%	8.56%	10.25%	8.48%
EBIT Margin	13.66%	4.04%	1.34%	-0.64%	7.98%	4.52%	5.05%	8.56%	10.25%	8.48%
Profit (Net Income) Margin	10.54%	2.86%	0.33%	-2.27%	5.31%	3.32%	3.01%	5.77%	7.07%	5.96%
Tax Burden Percent	79.37%	79.13%	42.11%	142.22%	79.75%	100.00%	80.45%	78.26%	76.86%	77.37%
Interest Burden Percent	97.19%	89.57%	59.38%	250.00%	83.45%	73.62%	74.07%	86.14%	89.70%	90.83%
Effective Tax Rate	20.63%	20.87%	57.89%	0.00%	20.25%	0.00%	19.55%	21.74%	23.14%	22.63%
Return on Invested Capital (ROIC)	35.16%	16.44%	6.26%	-1.42%	23.28%	11.18%	32.83%	35.14%	51.54%	14.20%
ROIC Less NNEP Spread (ROIC-NNEP)	33.60%	17.76%	5.73%	-3.89%	21.02%	8.42%	30.86%	33.97%	50.14%	13.14%
Return on Net Nonoperating Assets (RNNOA)	6.61%	-4.23%	3,744.60%	-5.75%	23.00%	3.59%	32,348.09%	56,175.06%	65,453.72%	6.02%
Return on Equity (ROE)	41.77%	12.21%	3,750.86%	-7.17%	46.28%	14.77%	32,380.92%	56,210.20%	65,505.25%	20.22%
Cash Return on Invested Capital (CROIC)	2.39%	-117.37%	72.91%	49.24%	58.26%	-31.28%	-51.47%	55.65%	82.01%	14.27%
Operating Return on Assets (OROA)	21.58%	6.56%	2.08%	-0.77%	10.55%	6.58%	7.80%	11.10%	13.37%	11.27%
Return on Assets (ROA)	16.65%	4.65%	0.52%	-2.74%	7.02%	4.84%	4.65%	7.48%	9.22%	7.92%
Return on Common Equity (ROCE)	0.00%	12.20%	0.00%	0.00%	0.00%	14.77%	0.00%	0.00%	0.00%	20.21%
Return on Equity Simple (ROE_SIMPLE)	19.10%	0.00%	18.16%	9.54%	5.79%	0.00%	8.46%	14.48%	14.62%	0.00%
Net Operating Profit after Tax (NOPAT)	65	18	2.69	-2.52	45	31	24	42	53	42
NOPAT Margin	10.86%	3.20%	0.56%	-0.45%	6.37%	4.52%	4.06%	6.70%	7.88%	6.56%
Net Nonoperating Expense Percent (NNEP)	1.57%	-1.32%	0.54%	2.47%	2.26%	2.76%	1.97%	1.17%	1.39%	1.05%
Return On Investment Capital (ROIC_SIMPLE)	-	2.23%	-	-	-	2.55%	-	-	-	3.53%
Cost of Revenue to Revenue	65.01%	63.44%	63.62%	61.74%	59.91%	59.83%	60.39%	58.10%	58.52%	59.47%
SG&A Expenses to Revenue	29.76%	31.46%	35.04%	37.44%	31.38%	31.04%	34.54%	33.01%	31.00%	31.64%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.31%	32.50%	35.04%	38.88%	32.12%	35.66%	34.56%	33.33%	31.24%	32.03%
Earnings before Interest and Taxes (EBIT)	82	23	6.40	-3.60	57	31	30	53	69	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	103	44	27	19	82	57	56	80	96	82
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.77	0.00	0.00	0.00	2.47	0.00	0.00	0.00	2.87
Price to Tangible Book Value (P/TBV)	0.00	6.18	0.00	0.00	0.00	17.18	0.00	0.00	0.00	11.19
Price to Revenue (P/Rev)	0.43	0.46	0.48	0.51	0.67	0.77	0.82	0.81	0.97	0.96
Price to Earnings (P/E)	8.80	8.81	9.84	16.56	36.48	38.26	31.75	18.54	20.01	17.31
Dividend Yield	5.11%	4.81%	4.84%	4.73%	3.81%	3.17%	2.88%	3.60%	2.47%	2.59%
Earnings Yield	11.36%	11.35%	10.16%	6.04%	2.74%	2.61%	3.15%	5.39%	5.00%	5.78%
Enterprise Value to Invested Capital (EV/IC)	1.52	1.60	6.79	3.01	4.27	1.96	5.71	5.94	9.11	2.35
Enterprise Value to Revenue (EV/Rev)	0.50	0.54	0.57	0.77	0.88	0.94	0.99	0.98	1.09	1.08
Enterprise Value to EBITDA (EV/EBITDA)	5.27	5.31	5.72	8.84	11.91	12.38	11.71	9.23	9.62	8.71
Enterprise Value to EBIT (EV/EBIT)	8.36	8.18	9.10	15.77	24.74	25.38	22.13	14.92	15.23	13.26
Enterprise Value to NOPAT (EV/NOPAT)	9.83	9.67	10.76	21.94	36.22	33.43	28.13	18.04	18.75	17.05
Enterprise Value to Operating Cash Flow (EV/OCF)	15.65	15.64	9.34	11.62	9.74	8.57	10.22	9.26	9.92	12.08
Enterprise Value to Free Cash Flow (EV/FCFF)	68.07	0.00	8.65	4.95	5.52	0.00	0.00	9.21	8.66	16.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.34	0.32	693.00	1,994.00	1,695.33	0.58	1,576.67	1,541.33	1,151.33	0.42
Long-Term Debt to Equity	0.34	0.32	687.67	1,990.33	1,644.00	0.57	1,534.00	1,372.33	981.67	0.36
Financial Leverage	0.20	-0.24	653.95	1.48	1.09	0.43	1,048.33	1,653.67	1,305.33	0.46
Leverage Ratio	2.45	2.41	4,674.93	6.51	5.79	2.43	5,492.33	6,694.00	6,550.67	2.37
Compound Leverage Factor	2.38	2.16	2,775.74	16.28	4.84	1.79	4,068.40	5,766.37	5,875.63	2.16
Debt to Total Capital	25.60%	24.28%	99.86%	99.95%	99.94%	36.81%	99.94%	99.94%	99.91%	29.61%
Short-Term Debt to Total Capital	0.15%	0.16%	0.77%	0.18%	3.03%	0.62%	2.70%	10.96%	14.72%	4.21%
Long-Term Debt to Total Capital	25.45%	24.12%	99.09%	99.77%	96.91%	36.18%	97.23%	88.98%	85.19%	25.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.04%	0.14%	0.05%	0.06%	0.02%	0.06%	0.06%	0.09%	0.03%
Common Equity to Total Capital	0.00%	75.68%	0.00%	0.00%	0.00%	63.17%	0.00%	0.00%	0.00%	70.36%
Debt to EBITDA	0.91	0.83	0.93	3.11	2.96	2.40	2.20	1.68	1.19	1.12
Net Debt to EBITDA	0.81	0.75	0.84	2.96	2.79	2.21	2.05	1.56	1.05	1.03
Long-Term Debt to EBITDA	0.91	0.82	0.92	3.11	2.87	2.36	2.14	1.49	1.02	0.96
Debt to NOPAT	1.70	1.51	1.74	7.73	9.01	6.47	5.29	3.28	2.33	2.20
Net Debt to NOPAT	1.51	1.36	1.58	7.35	8.48	5.97	4.93	3.04	2.06	2.02
Long-Term Debt to NOPAT	1.69	1.50	1.73	7.71	8.74	6.36	5.15	2.92	1.98	1.89
Altman Z-Score	2.53	3.14	2.59	1.62	2.02	2.71	2.55	2.59	2.88	3.32
Noncontrolling Interest Sharing Ratio	100.00%	0.05%	100.00%	100.00%	100.00%	0.04%	100.00%	100.00%	100.00%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.17	1.19	1.27	1.22	1.14	1.16	1.29	1.20	1.09	1.10
Quick Ratio	0.05	0.59	0.59	0.58	0.58	0.07	0.64	0.61	0.58	0.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-40	-653	32	263	359	-345	-228	177	226	48
Operating Cash Flow to CapEx	428.26%	258.47%	0.00%	0.00%	507.02%	648.15%	-40.19%	309.04%	924.46%	544.68%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.58	1.62	1.56	1.21	1.32	1.46	1.54	1.30	1.30	1.33
Accounts Receivable Turnover	0.00	10.44	10.37	0.00	0.00	0.00	12.21	10.17	9.91	0.00
Inventory Turnover	7.67	8.44	7.32	6.08	6.38	7.89	7.62	6.78	6.91	7.64
Fixed Asset Turnover	6.74	6.57	6.32	4.78	5.11	5.36	5.61	4.62	4.66	4.66
Accounts Payable Turnover	3.50	3.63	3.83	3.25	3.25	3.78	4.45	3.74	3.44	3.69
Days Sales Outstanding (DSO)	0.00	34.96	35.19	0.00	0.00	0.00	29.90	35.90	36.85	0.00
Days Inventory Outstanding (DIO)	47.61	43.23	49.83	60.07	57.17	46.27	47.91	53.86	52.82	47.78
Days Payable Outstanding (DPO)	104.27	100.58	95.38	112.15	112.26	96.60	81.98	97.66	106.08	99.00
Cash Conversion Cycle (CCC)	-56.66	-22.39	-10.35	-52.08	-55.09	-50.33	-4.18	-7.90	-16.42	-51.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	792	795	189	564	478	1,171	441	429	305	1,165
Invested Capital Turnover	3.24	5.14	11.14	3.17	3.66	2.48	8.08	5.24	6.54	2.16
Increase / (Decrease) in Invested Capital	105	671	-29	-266	-314	376	251	-135	-173	-6.00
Enterprise Value (EV)	1,205	1,270	1,284	1,698	2,044	2,292	2,514	2,545	2,783	2,739
Market Capitalization	1,019	1,091	1,095	1,129	1,565	1,882	2,073	2,116	2,478	2,414
Book Value per Share	$0.00	$14.90	$0.00	$0.00	$0.00	$16.35	$0.00	$0.00	$0.00	$17.57
Tangible Book Value per Share	($10.93)	$4.27	($10.45)	($16.83)	($14.89)	$2.35	($13.71)	($13.50)	($13.40)	$4.51
Total Capital	815	815	208	599	509	1,206	473	463	346	1,194
Total Debt	209	198	208	598	509	444	473	462	345	354
Total Long-Term Debt	207	197	206	597	493	436	460	412	295	303
Net Debt	186	178	189	569	478	409	441	429	305	325
Capital Expenditures (CapEx)	14	18	0.00	0.00	24	16	11	17	14	9.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	58	56	77	80	55	45	100	111	58	68
Debt-free Net Working Capital (DFNWC)	81	75	96	109	86	80	132	145	98	97
Net Working Capital (NWC)	80	74	95	108	70	72	120	94	47	47
Net Nonoperating Expense (NNE)	1.90	1.90	1.09	10	7.50	8.10	6.20	5.79	5.46	3.87
Net Nonoperating Obligations (NNO)	186	178	189	564	478	409	440	429	305	325
Total Depreciation and Amortization (D&A)	21	21	20	23	26	27	26	26	27	28
Debt-free, Cash-free Net Working Capital to Revenue	2.41%	2.37%	3.41%	3.61%	2.38%	1.86%	3.92%	4.27%	2.27%	2.71%
Debt-free Net Working Capital to Revenue	3.37%	3.19%	4.24%	4.95%	3.68%	3.27%	5.20%	5.55%	3.83%	3.85%
Net Working Capital to Revenue	3.32%	3.14%	4.17%	4.90%	3.02%	2.97%	4.70%	3.61%	1.85%	1.86%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.53	$0.38	$0.04	($0.30)	$0.81	$0.56	$0.38	$0.76	$1.00	$0.81
Adjusted Weighted Average Basic Shares Outstanding	41.30M	41.70M	41.50M	43.30M	46.60M	44.50M	47.10M	47.20M	47.70M	47.40M
Adjusted Diluted Earnings per Share	$1.51	$0.38	$0.04	($0.30)	$0.80	$0.55	$0.37	$0.75	$0.98	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	41.80M	42.20M	42.10M	43.30M	47.30M	45.40M	48.10M	48.20M	48.70M	48.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	41.36M	41.41M	41.70M	46.55M	46.58M	46.89M	47.30M	47.14M	47.80M	47.02M
Normalized Net Operating Profit after Tax (NOPAT)	25	18	4.48	3.15	50	43	24	43	54	44
Normalized NOPAT Margin	4.15%	3.20%	0.94%	0.56%	6.96%	6.39%	4.08%	6.95%	8.06%	6.86%
Pre Tax Income Margin	13.28%	3.62%	0.79%	-1.60%	6.66%	3.32%	3.74%	7.38%	9.19%	7.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	46.03%	42.94%	48.07%	80.79%	132.40%	118.90%	94.03%	54.34%	50.81%	45.59%
Augmented Payout Ratio	137.50%	95.56%	84.01%	80.79%	132.40%	119.51%	98.47%	66.35%	71.08%	92.76%

Frequently Asked Questions About HNI's Financials

When does HNI's fiscal year end?

According to the most recent income statement we have on file, HNI's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has HNI's net income changed over the last 2 years?

HNI's net income appears to be on an upward trend, with a most recent value of $139.50 million in 2024, rising from $123.90 million in 2022. The previous period was $49.20 million in 2023.

What is HNI's operating income?

HNI's total operating income in 2024 was $206.50 million, based on the following breakdown:

Total Gross Profit: $1.03 billion
Total Operating Expenses: $826.90 million

How has HNI revenue changed over the last 2 years?

Over the last 2 years, HNI's total revenue changed from $2.36 billion in 2022 to $2.53 billion in 2024, a change of 7.0%.

How much debt does HNI have?

HNI's total liabilities were at $1.03 billion at the end of 2024, a 11.3% decrease from 2023, and a 29.7% increase since 2022.

How much cash does HNI have?

In the past 2 years, HNI's cash and equivalents has ranged from $17.40 million in 2022 to $28.90 million in 2023, and is currently $22.50 million as of their latest financial filing in 2024.

How has HNI's book value per share changed over the last 2 years?

Over the last 2 years, HNI's book value per share changed from 14.90 in 2022 to 17.57 in 2024, a change of 17.9%.

Remove Ads

Related Companies

This page (NYSE:HNI) was last updated on 4/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HNI (HNI) Financials

Frequently Asked Questions About HNI's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HNI (HNI) Financials

Annual Income Statements for HNI

Quarterly Income Statements for HNI

Annual Cash Flow Statements for HNI

Quarterly Cash Flow Statements for HNI

Annual Balance Sheets for HNI

Quarterly Balance Sheets for HNI

Annual Metrics and Ratios for HNI

Quarterly Metrics and Ratios for HNI

Frequently Asked Questions About HNI's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools